J&M INNOVATIONS LTD

Executive Summary

J&M Innovations Ltd, a young real estate company, currently faces liquidity challenges with significant short-term liabilities exceeding its liquid assets and a negative net asset position. While the company holds valuable fixed assets, the heavy reliance on director loans and bank financing poses financial risks. Immediate focus on improving cash flow and managing debt will be essential to stabilize and strengthen its financial health moving forward.

J&M INNOVATIONS LTD - Analysis Report

Company Number: 14958550

Analysis Date: 2025-07-29 14:17 UTC

Financial Health Assessment for J&M Innovations Ltd as of 30 June 2024

---

1. Financial Health Score: D

Explanation:
J&M Innovations Ltd is a newly incorporated entity (since June 2023) operating in the real estate sector. The latest financials show a negative net asset position and working capital deficit, indicating financial stress symptoms. While the company holds significant fixed assets (investment property), its current liabilities far exceed current assets, creating liquidity concerns. The reliance on substantial director loans and bank financing adds to the risk profile. Overall, the financial health is below average for a company of this age and size, warranting careful monitoring and corrective action.

---

2. Key Vital Signs

Metric	Value	Interpretation
Fixed Assets	£106,312	Healthy investment in long-term assets (property + equipment).
Current Assets	£851	Very low short-term assets, indicating limited liquid resources.
Current Liabilities	£59,242	High short-term obligations, primarily director loans and bank overdrafts.
Net Current Assets (Working Capital)	-£50,176	Negative working capital ("symptom of distress")—short-term debts far outstrip liquid assets.
Net Assets (Shareholders’ Funds)	-£3,106	Negative equity signals an accounting insolvency position.
Director Loans	£48,327 (current liabilities)	Heavy reliance on insider funding, which may be a liquidity lifeline but also a risk.
Bank Loans (secured)	£61,942 total (short + long term)	Significant debt secured against assets; increases financial leverage and risk.
Profit and Loss Account	-£3,204	Accumulated losses exceeding share capital, reflecting early-stage trading losses or startup costs.
Average Employees	2	Very small operation consistent with micro/small enterprise.

---

3. Diagnosis: What the Financial Data Reveals About Business Health

• Liquidity Stress (Working Capital Deficit): The company has a very low level of cash and debtors (£851) against current liabilities exceeding £59k. This "symptom of distress" means the company may struggle to meet short-term obligations without additional financing or improved cash inflows.
• Negative Net Assets: The company is technically insolvent on a balance sheet basis with shareholders’ funds at -£3,106. This is not unusual for a startup but requires monitoring as it reflects accumulated losses and/or financing structure.
• Heavy Debt and Insider Loans: A large portion of current liabilities is director loans (£48,327), and bank loans are secured against assets (£61,942). While these provide essential funding, they increase financial risk and repayment obligations.
• Asset Base Concentrated in Investment Property: Fixed assets mainly comprise investment property valued at cost (£106,198). The directors believe market value is not materially different, indicating a relatively stable asset valuation. However, investment property is less liquid, which affects cash conversion ability.
• Early Stage Company Dynamics: Incorporated in mid-2023, the company is in its infancy and likely incurring startup expenses and initial losses, reflected in the P&L reserve negative balance.
• No Audit Required: The company qualifies for audit exemption under the small companies regime, typical for a micro/small entity.

---

4. Recommendations: Actions to Improve Financial Wellness

• Improve Liquidity Management:
  Focus on increasing cash balances and reducing current liabilities. This could involve negotiating longer payment terms with creditors, accelerating debtor collections, or injecting additional equity capital.

• Reduce Reliance on Director Loans:
  While director loans provide an emergency funding cushion, the company should aim to refinance or repay these to reduce risk and potential conflicts of interest.

• Review Debt Structure:
  Engage with lenders to explore restructuring bank debts or securing more favourable terms. High secured debt increases financial pressure, particularly on a startup.

• Asset Utilisation:
  Consider whether parts of the investment property portfolio can be monetised or leveraged more effectively to generate cash flow.

• Profitability Focus:
  Develop a clear plan to move towards operational profitability, including cost control and revenue growth strategies, especially since turnover and profit figures are not disclosed.

• Regular Financial Monitoring:
  Establish monthly cash flow forecasts and early warning indicators to detect and manage distress symptoms proactively.

• Governance and Compliance:
  Ensure timely filing of accounts and confirmation statements continues, maintaining good standing and external credibility.

---

Medical Analogy Summary:
J&M Innovations Ltd shows early "symptoms of distress" in the form of liquidity strain (negative working capital) and negative equity (net liabilities). The company's "vital signs" like fixed asset holdings are healthy, but the "circulatory system" (cash flow and short-term resources) is weak. Without intervention, these symptoms could worsen, potentially leading to "financial illness" such as insolvency. Prompt management of cash flow and debt is critical to restore "financial health."

---